Evaluating the effect of reducing the number of cancer cells and intraperitoneal chemotherapy in patients with advanced peritoneal carcinoma
Not Applicable
- Conditions
- eoplasm.Malignant neoplasm of ovary
- Registration Number
- IRCT201112088331N1
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Patients with primary ovarian cancer who have not been previously treated for the cancer and in whom abdominal carcinomatosis is confirmed before or during surgical interventions. Exclusion criteria: Patient dissatisfaction; Patient intolerance;Lymph node metastasis; Systemic metastasis; No cytoreductive surgery (residue less than 1 cm); PS< 80%; Age> 70 years; Adhesions which are resistant to enterolysis.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Disease- free survival. Timepoint: At intervals of 6 and 9 months, and then every 3 months up to 5 yeras after intervention. Method of measurement: Month.
- Secondary Outcome Measures
Name Time Method Intraperitoneal recurrence. Timepoint: In follow up studies. Method of measurement: Clinical or Paraclinical.;Surgical Complications. Timepoint: In early follow up studies. Method of measurement: Clinical or Paraclinical.;Ovarian cancer. Timepoint: In the follow up studies. Method of measurement: In biopsy.